dc.contributor.author | Güler, Ekrem | |
dc.contributor.author | Babür Güler, Gamze | |
dc.contributor.author | Demir, Gültekin Günhan | |
dc.contributor.author | Hatipoǧlu, Suzan | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T19:37:05Z | |
dc.date.available | 10.07.201910:49:14 | |
dc.date.available | 2019-07-10T19:37:05Z | |
dc.date.issued | 2016 | en_US |
dc.identifier.citation | Güler, E., Babür Güler, G., Demir, G. G. ve Hatipoǧlu, S. (2016). Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight. Anatolian Journal of Cardiology, 16(3), 220-221. | en_US |
dc.identifier.issn | 2149-2263 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/1325 | |
dc.description.abstract | We have read with great interest the manuscript by Housseinsabet (1) entitled “Assessment of atrial conduction times in patients with mild diastolic dysfunction and normal atrial size,” published in the Anatolian Journal of Cardiology 2015; 15: 925-31. In this study, Hosseinsabet (1) clearly demonstrated that there were no differences in atrial conduction times (ACTs) and atrial electromechanical delays (EMDs) in patients with mild diastolic dysfunction and normal left atrial volume compared with normal subjects. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Turkish Society of Cardiology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Anticoagulants | en_US |
dc.subject | Atrial Fibrillation | en_US |
dc.subject | Dabigatran Rivaroxaban | en_US |
dc.title | Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight | en_US |
dc.type | letter | en_US |
dc.relation.ispartof | Anatolian Journal of Cardiology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-4607-5724 | en_US |
dc.authorid | 0000-0001-9975-5507 | en_US |
dc.identifier.volume | 16 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 220 | en_US |
dc.identifier.endpage | 221 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.scopusquality | Q3 | en_US |